The High-Flux research reactor owned by the European Union and managed by NRG at Petten in the Netherlands hit record production in May and was able to continue to provide 30,000 patients daily with medical isotopes.
NRG said the coronavirus pandemic has “caused complications” for transport and logistics and because to this NRG has had to ensure reliable levels of production at Petten.
The logistics process for delivering isotope has become more complicated because of the pandemic with the transportation of nuclear medicine to hospitals taking longer.
NRG said the coronavirus pandemic has “caused complications” for transport and logistics and because to this NRG has had to ensure reliable levels of production at Petten.
The logistics process for delivering isotope has become more complicated because of the pandemic with the transportation of nuclear medicine to hospitals taking longer.
Want to keep reading?
Register free and get full access to NucNet for 14 days. No card required.
- Daily news briefing on the global nuclear industry
- Weekly, monthly and topical newsletters
- 24/7 coverage during nuclear incidents and safety events
- Full searchable archive, 30,000+ articles since 1991
- SMR and AMR project database
- Analysis, Focus pieces and infographics
- NucNet Style Guide for nuclear reporters and communicators
After the trial, keep a free account for a newsletter and a complimentary Plus article every two weeks. Or see our subscription plans for individuals and organisations.
See subscription options
